Ginkgo Bioworks Holdings, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2024 Annual Meeting of Shareholders held by Ginkgo Bioworks Holdings, Inc. on June 13, 2024. The filing details the voting outcomes for director elections, auditor ratification, and executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Shareholders representing approximately 82.93% of Class A and Class B common stock (voting as a single class) and 92.33% of Class B common stock (voting separately) participated in the meeting. The following matters were approved:
- Election of Directors: All nine nominees were elected. This included two nominees elected by Class B shareholders (Jason Kelly and Reshma Shetty) and seven nominees elected by Class A and Class B shareholders voting together (Arie Belldegrun, Ross Fubini, Kathy Hopinkah Hannan, Christian Henry, Myrtle Potter, Shyam Sankar, and Harry E. Sloan).
- Auditor Ratification: Shareholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
- Executive Compensation: The advisory vote to approve the compensation of named executive officers was approved.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total number of shares present or represented by proxy: 1,374,218,617 Class A shares and 353,238,955 Class B shares.
- Note the significant number of broker non-votes (272,797,028) on the director election and executive compensation proposals.
- Confirm the specific vote counts for director nominees, particularly Shyam Sankar and Kathy Hopinkah Hannan, who received higher "Against" votes compared to other nominees.
- Verify the ratification of Deloitte & Touche LLP for the fiscal year ending December 31, 2024.